skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2089-2098 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa539 ;PMID: 32361738

Full text available

Citations Cited by
  • Title:
    Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China
  • Author: Hu, Ling ; Chen, Shaoqiu ; Fu, Yuanyuan ; Gao, Zitong ; Long, Hui ; Ren, Hong-wei ; Zuo, Yi ; Wang, Jie ; Li, Huan ; Xu, Qing-bang ; Yu, Wen-xiong ; Liu, Jia ; Shao, Chen ; Hao, Jun-jie ; Wang, Chuan-zhen ; Ma, Yao ; Wang, Zhanwei ; Yanagihara, Richard ; Deng, Youping
  • Subjects: Adult ; Aged ; Aged, 80 and over ; Chi-Square Distribution ; China - epidemiology ; Coronavirus - pathogenicity ; COVID-19 - epidemiology ; Female ; Hospitalization - statistics & numerical data ; Humans ; Hypnotics and Sedatives - therapeutic use ; Male ; Middle Aged ; Obesity - complications ; Obesity - epidemiology ; Retrospective Studies ; Risk Factors ; Young Adult
  • Is Part Of: Clinical infectious diseases, 2020-11, Vol.71 (16), p.2089-2098
  • Description: Abstract Background With evidence of sustained transmission in more than 190 countries, coronavirus disease 2019 (COVID-19) has been declared a global pandemic. Data are urgently needed about risk factors associated with clinical outcomes. Methods A retrospective review of 323 hospitalized patients with COVID-19 in Wuhan was conducted. Patients were classified into 3 disease severity groups (nonsevere, severe, and critical), based on initial clinical presentation. Clinical outcomes were designated as favorable and unfavorable, based on disease progression and response to treatments. Logistic regression models were performed to identify risk factors associated with clinical outcomes, and log-rank test was conducted for the association with clinical progression. Results Current standard treatments did not show significant improvement in patient outcomes. By univariate logistic regression analysis, 27 risk factors were significantly associated with clinical outcomes. Multivariate regression indicated age >65 years (P < .001), smoking (P = .001), critical disease status (P = .002), diabetes (P = .025), high hypersensitive troponin I (>0.04 pg/mL, P = .02), leukocytosis (>10 × 109/L, P < .001), and neutrophilia (>75 × 109/L, P < .001) predicted unfavorable clinical outcomes. In contrast, the administration of hypnotics was significantly associated with favorable outcomes (P < .001), which was confirmed by survival analysis. Conclusions Hypnotics may be an effective ancillary treatment for COVID-19. We also found novel risk factors, such as higher hypersensitive troponin I, predicted poor clinical outcomes. Overall, our study provides useful data to guide early clinical decision making to reduce mortality and improve clinical outcomes of COVID-19. This study identified 27 risk factors associated with COVID-19 clinical outcomes. The administration of hypnotics was significantly associated with favorable outcomes for COVID-19. Novel risk factors, such as higher hypersensitive troponin I, were found to predict poor clinical outcomes.
  • Publisher: US: Oxford University Press
  • Language: English
  • Identifier: ISSN: 1058-4838
    EISSN: 1537-6591
    DOI: 10.1093/cid/ciaa539
    PMID: 32361738
  • Source: MEDLINE
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait